Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
|
|
INTERMOLECULAR INC (IMI)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 09/30/2019 |
15-12B
| Form 15-12B - Securities registration termination [Section 12(b)]: |
| 09/24/2019 |
4
| MARTIN WILLIAM C (10% Owner) has filed a Form 4 on INTERMOLECULAR INC|
Txns:
| Unknown transaction of 14,731,351 shares
@ $1.2, valued at
$17.7M
|
|
| 09/24/2019 |
SC 13D/A
| Raging Capital Management, LLC reports a 0% stake in Intermolecular, Inc. |
| 09/23/2019 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 09/23/2019 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 09/23/2019 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 09/23/2019 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 09/23/2019 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 09/23/2019 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 09/23/2019 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 09/23/2019 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 09/23/2019 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 09/20/2019 |
4
| Furnas Matthew (Director) has filed a Form 4 on INTERMOLECULAR INC|
Txns:
| Unknown transaction of 75,000 options
@ $0.96, valued at
$72k
Unknown transaction of 25,000 options
@ $1.39, valued at
$34.8k
|
|
| 09/20/2019 |
4
| BURKETT MARVIN D (Director) has filed a Form 4 on INTERMOLECULAR INC|
Txns:
| Unknown transaction of 12,500 options
@ $6.2, valued at
$77.5k
Unknown transaction of 10,000 options
@ $6.62, valued at
$66.2k
Unknown transaction of 10,000 options
@ $8.21, valued at
$82.1k
Unknown transaction of 10,000 options
@ $2.59, valued at
$25.9k
Unknown transaction of 25,000 options
@ $1.82, valued at
$45.5k
Unknown transaction of 25,000 options
@ $1.85, valued at
$46.3k
Unknown transaction of 25,000 options
@ $0.85, valued at
$21.3k
Unknown transaction of 25,000 options
@ $1.39, valued at
$34.8k
|
|
| 09/20/2019 |
4
| TRAUB KENNETH H (Director) has filed a Form 4 on INTERMOLECULAR INC|
Txns:
| Unknown transaction of 75,000 options
@ $1.85, valued at
$138.8k
Unknown transaction of 25,000 options
@ $0.85, valued at
$21.3k
Unknown transaction of 25,000 options
@ $1.39, valued at
$34.8k
|
|
| 09/20/2019 |
4
| Schultz Jonathan B. (Director) has filed a Form 4 on INTERMOLECULAR INC|
Txns:
| Unknown transaction of 75,000 options
@ $1.39, valued at
$104.3k
|
|
| 09/20/2019 |
4
| FEDERMAN IRWIN (10% Owner) has filed a Form 4 on INTERMOLECULAR INC|
Txns:
| Unknown transaction of 538,267 shares
@ $0
Unknown transaction of 10,000 options
@ $6.62, valued at
$66.2k
Unknown transaction of 10,000 options
@ $8.21, valued at
$82.1k
Unknown transaction of 10,000 options
@ $2.59, valued at
$25.9k
Unknown transaction of 25,000 options
@ $1.82, valued at
$45.5k
Unknown transaction of 25,000 options
@ $1.85, valued at
$46.3k
Unknown transaction of 25,000 options
@ $0.85, valued at
$21.3k
Unknown transaction of 25,000 options
@ $1.39, valued at
$34.8k
|
|
| 09/20/2019 |
4
| SCALISE GEORGE (Director) has filed a Form 4 on INTERMOLECULAR INC|
Txns:
| Unknown transaction of 160,000 shares
@ $0
Unknown transaction of 10,000 options
@ $6.62, valued at
$66.2k
Unknown transaction of 10,000 options
@ $8.21, valued at
$82.1k
Unknown transaction of 10,000 options
@ $2.59, valued at
$25.9k
Unknown transaction of 25,000 options
@ $1.82, valued at
$45.5k
Unknown transaction of 25,000 options
@ $1.85, valued at
$46.3k
Unknown transaction of 25,000 options
@ $0.85, valued at
$21.3k
Unknown transaction of 25,000 options
@ $1.39, valued at
$34.8k
|
|
| 09/20/2019 |
4
| Kramer Christian (President and CEO) has filed a Form 4 on INTERMOLECULAR INC|
Txns:
| Unknown transaction of 850,000 shares
@ $0
Unknown transaction of 1,000,000 options
@ $1.35, valued at
$1.4M
Unknown transaction of 200,000 options
@ $0.83, valued at
$166k
Unknown transaction of 150,000 options
@ $1.3501, valued at
$202.5k
|
|
| 09/20/2019 |
4
| ROESCHLEIN BILL (CFO) has filed a Form 4 on INTERMOLECULAR INC|
Txns:
| Unknown transaction of 260,000 shares
@ $0
Unknown transaction of 100,000 options
@ $2.04, valued at
$204k
Unknown transaction of 54,000 options
@ $0.99, valued at
$53.5k
Unknown transaction of 250,000 options
@ $0.9, valued at
$225k
Unknown transaction of 60,000 options
@ $1.3501, valued at
$81k
|
|
| 09/20/2019 |
4
| Scheer Adam Louis Abraham (Director) has filed a Form 4 on INTERMOLECULAR INC|
Txns:
| Unknown transaction of 75,000 options
@ $1.39, valued at
$104.3k
|
|
| 09/20/2019 |
25-NSE
| Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities: |
| 09/20/2019 |
8-K
| Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Sta... |
| 08/14/2019 |
SC 13D/A
| Merck KGaA reports a 31% stake in INTERMOLECULAR, INC. |
| 08/08/2019 |
10-Q
| Quarterly Report for the period ended June 30, 2019 |
| 08/08/2019 |
8-K
| Quarterly results |
| 07/17/2019 |
8-K
| Submission of Matters to a Vote of Security Holders, Other Events, Financial Statements and Exhibits |
| 06/28/2019 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 06/12/2019 |
DEFM14A
| Form DEFM14A - Definitive proxy statement relating to merger or acquisition: |
| 05/28/2019 |
PREM14A
| Form PREM14A - Preliminary proxy statements relating to merger or acquisition: |
| 05/16/2019 |
SC 13D
| Merck KGaA reports a 31% stake in INTERMOLECULAR, INC. |
| 05/16/2019 |
SC 13D
| GAMCO INVESTORS, INC. ET AL reports a 3.6% stake in Intermolecular, Inc. |
| 05/14/2019 |
10-Q
| Quarterly Report for the period ended March 31, 2019 |
| 05/14/2019 |
8-K
| Quarterly results |
|
|
|